Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of preoperative frailty assessment on peri-operative complications and cancer related outcomes in advanced stage endometrial cancer.

Gynecologic oncology reports·2026
Same author

Juvenile granulosa cell tumor in an adult woman during pregnancy: A case report and review of the literature.

Gynecologic oncology reports·2023
Same author

Implementation of an enhanced recovery protocol in gynecologic oncology.

Gynecologic oncology reports·2021
Same author

Disparities Among Cervical Cancer Patients Receiving Brachytherapy.

Obstetrics and gynecology·2019
Same author

Implementation of an abdominal closure bundle to reduce surgical site infection in patients on a gynecologic oncology service undergoing exploratory laparotomy.

Gynecologic oncology·2018
Same author

Recognition and Therapeutic Options for Malignancy of the Cervix and Uterus.

Obstetrics and gynecology clinics of North America·2017

Related Experiment Video

Updated: May 20, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Endometrial cancer.

Joel I Sorosky1

  • 1Department of Obstetrics and Gynecology, Hartford Hospital, The University of Connecticut, Hartford, Connecticut 062102, USA. jsorosk@harthosp.org

Obstetrics and Gynecology
|July 25, 2012
PubMed
Summary

Endometrial cancer incidence and mortality are rising. Early detection and management by experienced physicians are crucial for improved outcomes in this complex gynecologic malignancy.

Area of Science:

  • Gynecologic Oncology
  • Epidemiology
  • Clinical Management

Background:

  • Endometrial carcinoma incidence has risen 21% since 2008, with a >100% increase in mortality over two decades.
  • Complex hyperplasia with atypia is a precursor lesion in over 40% of endometrial cancer cases.
  • Disparities exist, with white women having twice the incidence but black women facing a less favorable prognosis stage-for-stage.

Purpose of the Study:

  • To review the epidemiology, prevention, diagnosis, treatment, prognosis, and staging of endometrial carcinoma.
  • To highlight current challenges and controversies in surgical staging and lymphadenectomy.
  • To discuss emerging research and management strategies for endometrial cancer.

Main Methods:

  • Comprehensive review of epidemiological data and clinical management guidelines for endometrial cancer.

More Related Videos

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
05:42

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

Related Experiment Videos

Last Updated: May 20, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
05:42

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

  • Analysis of diagnostic accuracy limitations in preoperative imaging and gross examination for surgical decision-making.
  • Evaluation of current controversies in surgical staging, including lymphadenectomy and minimally invasive techniques.

    • Main Results:

    • Preoperative imaging and gross examination lack accuracy for assessing lymph node involvement and myometrial invasion, respectively.
    • The therapeutic value and extent of pelvic lymphadenectomy remain controversial in surgical staging.
    • Minimally invasive surgery is now standard; research focuses on identifying early-stage patients amenable to less extensive surgery.

    Conclusions:

    • Endometrial cancer management requires experienced multidisciplinary care due to its complexity and rising trends.
    • Accurate staging remains critical, with ongoing research to refine surgical approaches and identify patients for conservative management.
    • Risk factors include family history of hereditary nonpolyposis colorectal cancer, necessitating tailored screening and prevention strategies.